Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes
NCT01192659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16492
Last updated 2016-12-01
Summary
The purpose of this study is to identify risk factors for low lymphocyte count among patients with type 2 diabetes who are treated with oral antidiabetic drugs.
Conditions
- Diabetes Mellitus, Type 2
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
More Related Trials
-
SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
NCT07198191 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
NCT01900834 ·Status: COMPLETED
-
SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes
NCT05256706 ·Status: COMPLETED ·Phase: NA
-
Investigating the Insulin Resistance in Individuals With Type 2 Diabetes
NCT06428968 ·Status: RECRUITING ·Phase: NA
-
Egg Intake and Risk of Type 2 Diabetes
NCT03406910 ·Status: COMPLETED
-
Korea National Diabetes Program
NCT01212198 ·Status: UNKNOWN
-
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.
NCT03010956 ·Status: COMPLETED
-
Diagnosis of Insulin Resistance: 13C-Glucose Breath Test Vs HOMA Index.
NCT00264940 ·Status: UNKNOWN
-
Exercise-induced Blood Glucose Response in Patients With Type 2 Diabetes
NCT03335930 ·Status: COMPLETED ·Phase: NA
-
A Randomized Trial to Slow the Progression of Diabetes
NCT03800680 ·Status: COMPLETED ·Phase: NA
-
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
NCT05040087 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sweet Sensing in Type 2 Diabetes
NCT06804187 ·Status: ENROLLING_BY_INVITATION
-
Neutrophil-lymphocyte and Platelet-lymphocyte Ratios and Their Relations to Vascular Comlications and Glycemic Control in Patients With Type 2 Diabetes Attending The Diabetes Center of Assiut University Hospitals
NCT06073756 ·Status: NOT_YET_RECRUITING
-
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
NCT01105858 ·Status: SUSPENDED
-
Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)
NCT01218061 ·Status: UNKNOWN ·Phase: NA
-
The Early Predictors for Developing Type 2 Diabetes Mellitus in Patients With Chronic Obstructive Pulmonary Disease
NCT03152994 ·Status: COMPLETED
-
Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes
NCT01926925 ·Status: COMPLETED
-
Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes
NCT05925829 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes
NCT05609279 ·Status: COMPLETED
-
Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism, Excretion of DA-1229
NCT02267902 ·Status: UNKNOWN ·Phase: PHASE1
-
Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients
NCT02026024 ·Status: COMPLETED
-
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
NCT02885922 ·Status: UNKNOWN
-
Subjects With T2D or at Risk of T2D Cohort Follow-up
NCT05567692 ·Status: SUSPENDED
-
Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes
NCT01494298 ·Status: COMPLETED
-
The Prevalence of Autoimmune Antibodies in Patients with Type 2 Diabetes Managed by Endocrinology Vs. Primary Care
NCT05553145 ·Status: COMPLETED